StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
38 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

StemCells, Inc. (StemCells), a subsidiary of Stem Cell Sciences UK Ltd is a pharmaceutical company that develops cell based therapeutics and related tools. The company provides research on products for spinal cord injury, thoracic injury, cervical injury, retinal disorders, dry age-related macular degeneration, neurodegenerative diseases, neuronal ceroid lipofuscinosis, and pelizaeus-merzbacher disease. StemCells provides clinical development of proprietary HuCNS-SC purified human neural stem cells platform technology for the treatment of human central nervous system. The companys products are used in stem cell-based drug discovery and research. It has operations in Switzerland and the US.

StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which hav

  
Source:
Document ID
GDPH116426D
Country
Industry
Ticker
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
StemCells, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
StemCells, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
StemCells, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
StemCells, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
StemCells, Inc., Medical Devices Deals, 2010 to YTD 201691
StemCells, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
StemCells, Inc., Pharmaceuticals &Healthcare, Deal Details1124
  Asset Purchase111
    StemCells Acquires Seminal Neural Stem Cell Patent Portfolio From NeuroSpheres112
  Partnerships131
    StemCells Enters Into Agreement With R Biomedical To Develop Reagents For Human iPS Cell Research131
  Licensing Agreements141
    StemCells Enters Into Licensing Agreement With genOway For Internal Ribosome Entry Site Technology141
    StemCells Enters Into Licensing Agreement With Children's Hospital of Orange County151
  Equity Offering161
    StemCells Files Registration Statement for Rights Offering of Shares for up to USD30 Million161
    StemCells Raises USD8 Million in Public Offering of Shares and Warrants172
    StemCells Completes Exercise of Underwriter's Over Allotment Option for Public Offering of Shares and Warrants for USD27 Million192
    StemCells Raises USD20 Million in Private Placement of Units212
    StemCells Files Registration Statement For IPO To Raise Up To US$100 Million231
    StemCells Terminates Private Placement Of Shares For US$31 Million242
    StemCells Completes Public Offering Of Units For US$18.6 Million261
    StemCells Completes Public Offering Of Shares For US$1.6 Million272
    StemCells Completes Public Offering Of Units For US$10 Million292
    StemCells Completes Private Placement Of Its Common Stock For US$10 Million312
    StemCells Completes Private Placement For US$6 Million332
StemCells, Inc. - Key Competitors351
Key Employees361
Locations And Subsidiaries371
  Head Office371
Appendix381
  Methodology381
  About GlobalData381
  Contact Us381
  Disclaimer381

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/StemCells-Inc-STEM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13676>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/StemCells-Inc-STEM-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13676>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research